Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-98-000682
Filing Date
1998-03-13
Accepted
1998-03-13 00:00:00
Documents
16
Period of Report
1997-12-31
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DEC. 31, 1997 10-K 86488
2 SECOND AMENDMENT TO RESTATED STOCK OWNERSHIP PLAN EX-10.7 4615
3 SECOND AMENDMENT TO SAVINGS AND INVESTMENT PLAN EX-10.10 4646
4 FORM OF ALLERGAN CHANGE IN CONTROL SEVERANCE AGMT EX-10.11 35767
5 FIRST AMENDMENT TO THE ALLERGAN, INC. PENSION PLAN EX-10.14 5060
6 ALLERGAN, INC. MANAGEMENT BONUS PLAN EX-10.17 8703
7 ALLERGAN, INC. STOCK PRICE INCENTIVE PLAN EX-10.21 18679
8 LETTER AGREEMENT BETWEEN CO. AND WILLIAM SHEPHERD EX-10.22 14838
9 TECHNOLOGY LICENSE AGREEMENT DATED MARCH 6, 1998 EX-10.23 30304
10 RESEARCH AND DEVELOPMENT AGREEMENT DATED 3-6-1998 EX-10.24 52027
11 LICENSE OPTION AGREEMENT DATED MARCH 6, 1998 EX-10.25 46529
12 DISTRIBUTION AGREEMENT DATED MARCH 6, 1998 EX-10.26 19478
13 THE COMPANY'S ANNUAL REPORT TO SHAREHOLDERS EX-13 139446
14 LIST OF SUBSIDIARIES OF THE COMPANY EX-21 5165
15 REPORT AND CONSENT OF KPMG EX-23 1639
16 FINANCIAL DATA SCHEDULE EX-27 2294
  Complete submission text file 0000892569-98-000682.txt   478913
Mailing Address 2525 DUPONT DRIVE IRVINE CA 92715
Business Address 2525 DUPONT DR IRVINE CA 92612 7147524500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10269 | Film No.: 98564728
SIC: 2834 Pharmaceutical Preparations